Table S1. Univariate analysis of EFS and OS.
| Variables | EFS | OS | |||
|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | ||
| PANK2 (high vs. low) | 0.526 (0.317–0.846) | 0.008 | 0.560 (0.348–0.904) | 0.018 | |
| PANK4 (high vs. low) | 1.726 (1.071–2.779) | 0.025 | 1.804 (1.114–2.922) | 0.017 | |
| Age (≥60 vs. <60 years) | 3.146 (1.748–5.663) | 0.000 | 3.151 (1.731–5.738) | 0.000 | |
| WBC (≥15 vs. <15×109/L) | 1.123 (0.704–1.792) | 0.625 | 1.102 (0.689–1.762) | 0.685 | |
| BM blasts (≥70% vs. <70%) | 1.525 (0.859–2.706) | 0.150 | 1.742 (1.071–2.835) | 0.025 | |
| PB blasts (≥70% vs. <70%) | 1.880 (1.158–3.052) | 0.011 | 1.237 (0.687–2.227) | 0.479 | |
| FLT3-ITD (positive vs. negative) | 1.136 (0.621–2.077) | 0.679 | 1.095 (0.599–2.003) | 0.768 | |
| NPM1 (mutated vs. wild) | 1.311 (0.799–2.149) | 0.284 | 1.163 (0.704–1.920) | 0.556 | |
| DNMT3A (mutated vs. wild) | 1.747 (1.049–2.911) | 0.032 | 1.676 (1.001–2.806) | 0.050 | |
| NRAS/KRAS (mutated vs. wild) | 1.042 (0.533–2.038) | 0.904 | 1.087 (0.555–2.127) | 0.808 | |
| IDH1/IDH2 (mutated vs. wild) | 0.994 (0.552–1.787) | 0.983 | 0.951 (0.519–1.741) | 0.870 | |
| TET2 (mutated vs. wild) | 0.835 (0.414–1.682) | 0.613 | 0.742 (0.368–1.499) | 0.406 | |
| TP53 (mutated vs. wild) | 3.203 (1.658–6.184) | 0.001 | 3.166 (1.644–6.099) | 0.001 | |
| RUNX1 (mutated vs. wild) | 1.478 (0.704–3.102) | 0.302 | 1.619 (0.770–3.405) | 0.204 | |
EFS, event-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; WBC, white blood cell; BM, bone marrow; PB, peripheral blood.